Ramesh Poluru
Pediatrics — INCLEN Trust International, India
Ramesh Poluru
LeadR Profile
Pediatrics
Subspecialties: Public Health - Biochemistry - Neurology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Ramesh Poluru holds a Masters and PhD in Population Studies along with a Post-graduate diploma in computer applications from Sri Venkateswara University, Tirupati, India. His interests and expertise spans across demography, statistics, epidemiology, infectious diseases, vaccine safety, impact assessment, demographic and public health surveillance (reproductive and child health, STIs, HIV/AIDS etc.). Dr Poluru has more than two decades of experience in conceptualization, implementation and monitoring of large scale socioeconomic, demographic, behavioural, biological and operations research studies; analysis and interpretation of data (primary and secondary), using both qualitative and quantitative approaches. He has also extensively involved in the facility, community-based studies, action/operations research, phase-3 & 4 clinical trials, to deliver intervention services among general population (women and children) to more vulnerable populations (infants, minority population, high-risk groups: female sex workers, MSM, IDU and truckers). Dr Poluru has authored and co-authored about 60 research papers in peer-reviewed journals/chapters, national and international technical reports. Dr Poluru contributed to the development of international pediatric randomized trial reporting standards (CONSORT, SPIRIT and TIDieR-Children and Adolescents extensions). He has also contributed to the Global Burden of Disease Study 2019, 2021, 2023 providing comprehensive assessments of health outcomes and risk factors.
Organizations
Career arc: 2013 - 2026
Number : 62
Citations
Main journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Stillbirths at 22- and 28-weeks' gestation or longer for the states in India: findings from the Global Burden of Disease Study 2023. pregnancy, mortality, stillbirth, infant mortality, global burden of disease, cost of illness | Lancet Reg Health Southeast Asia | 2026 | 0 |
| Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023. myocardial ischemia, heart diseases, cholesterol, ldl, growth, ischemic stroke, stroke, heart, aging, uncertainty, global burden of disease, cost of illness, therapeutics, demography | JAMA Top journal | 2026 | 0 |
| Mapping drivers of life expectancy change in Asia from 1990 to 2023. mortality, income, life expectancy, risk factors, pandemics | Nature Top journal | 2026 | 0 |
| Author Correction: Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990-2023: a Global Burden of Disease Study. cocaine, molecular biology, global burden of disease, cost of illness, amphetamine | Nat Med Top journal | 2026 | 0 |
| CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trials. caregivers, adolescent, research, pediatrics, child | Lancet Child Adolesc Health | 2026 | 0 |
LeadR Networks
Main global connection map